Japan

Japan-Bermuda Bilateral Meeting on Insurance

The Japan Financial Services Agency (JFSA) and the Bermuda Monetary Authority (BMA) held a bilateral meeting on February 25, 2026, in Tokyo. The meeting focused on insurance-related regulatory and supervisory matters, including international priorities and opportunities for closer collaboration.

Japan-UK Financial Regulatory Forum Discusses Key Topics

The Japan Financial Services Agency (JFSA) and UK authorities (HM Treasury, Bank of England, FCA) held the fourth Japan-UK Financial Regulatory Forum on March 18, 2026. Discussions covered digital finance, sustainable finance, AI, cybersecurity, and international banking regulations.

JFTC Reviews Adobe Figma Acquisition and Cautions Logic Inc.

The Japan Fair Trade Commission (JFTC) has closed its review of Adobe Inc.'s proposed acquisition of Figma, Inc., indicating no immediate concerns. Separately, the JFTC issued a caution to Logic Inc. regarding potential violations of the Antimonopoly Act.

JFTC Investigates Microsoft for Antimonopoly Act Violation

The Japan Fair Trade Commission (JFTC) has opened an investigation into Microsoft Corporation for suspected violations of the Antimonopoly Act. The JFTC is seeking information and comments from third parties regarding the alleged anti-competitive practices.

Japan Fair Trade Commission Press Releases 2025

The Japan Fair Trade Commission (JFTC) has published its press releases for 2025, detailing various activities including merger reviews, enforcement actions, and the issuance of guidance. These releases cover a range of industries and regulatory matters handled by the JFTC throughout the year.

JFTC Issues Cease and Desist Order to MC Data Plus

The Japan Fair Trade Commission (JFTC) has issued a cease and desist order to MC Data Plus, Inc. for alleged violations of the Antimonopoly Act. This action indicates potential anticompetitive practices by the company.

Japan Fair Trade Commission Press Releases 2022

The Japan Fair Trade Commission (JFTC) has released its press releases for 2022, detailing various enforcement actions, training courses, and participation in international competition events. These announcements cover a range of antitrust and competition policy matters.

Japan PMDA Drug Precaution Revisions for FY2025

The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has published a list of drug precaution revisions for Fiscal Year 2025, detailing updates for various nonproprietary drug names. These revisions are effective on specific dates in late 2025 and early 2026, with associated investigation summaries available.

PMDA Japan Drug Precaution Revisions

The PMDA Japan has updated drug precautions for several medications, including Andexanet alfa, Topiramate, and various VEGF/VEGFR inhibitors. These revisions reflect new safety information and investigation results, impacting the labeling and handling of these drugs.

FSA Publishes English Version of Analytical Notes (2026.3)

The Financial Services Agency (FSA) of Japan has published the English version of its "FSA Analytical Notes (2026.3)". This publication provides analysis on financial markets and related topics, with specific notes on the OTC derivatives market.